Bionovo, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bionovo with three other
companies in this sector in the United States:
Achillion Pharmaceuticals, Inc.
(2011
sales of $247,000.00
of which 100%
was Anti-infective Drug),
Generex Biotechnology Corporation
($291,628.00
of which 100%
was Drug Delivery Technology), and
Radient Pharmaceuticals Corporation
($313,559.00
of which 100%
was Corporate).
Sales Analysis.
During the year ended December of 2011, sales at
Bionovo were $265,000.00 .
This
is
a
sharp
decrease of 56.8%
versus 2010, when the company's sales were $613,000.00 .
Business Description